Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Luminex Corp (LMNX)

Luminex Corp (LMNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Luminex Corp 12212 TECHNOLOGY BLVD AUSTIN TX 78727 USA

www.luminexcorp.com P: 512-219-8020 F: 512-219-5195

Description:

Luminex Corporation is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.

Key Statistics

Overview:

Market Capitalization, $K 1,750,145
Shares Outstanding, K 47,314
Annual Sales, $ 417,400 K
Annual Net Income, $ 15,170 K
Last Quarter Sales, $ 110,690 K
Last Quarter Net Income, $ 9,080 K
60-Month Beta 0.56
% of Insider Shareholders 6.60%
% of Institutional Shareholders 87.76%
Float, K 44,191
% Float 93.40%

Growth:

1-Year Return 14.88%
3-Year Return 11.01%
5-Year Return 67.68%
5-Year Revenue Growth 75.59%
5-Year Earnings Growth -70.09%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.01 on 02/08/21
Next Earnings Date 08/03/21
Earnings Per Share ttm 0.51
EPS Growth vs. Prev Qtr 1,800.00%
EPS Growth vs. Prev Year 1,800.00%
Annual Dividend Rate, $ 0.40
Annual Dividend Yield 1.08%
Most Recent Dividend 0.100 on 06/16/21
Next Ex-Dividends Date 06/16/21
Dividend Payable Date 07/08/21
Dividend Payout Ratio 74.87%

LMNX Ratios

Ratio
Price/Earnings ttm 72.51
Price/Earnings forward 39.56
Price/Earnings to Growth N/A
Return-on-Equity % 4.66%
Return-on-Assets % 2.91%
Profit Margin % 3.63%
Debt/Equity 0.52
Price/Sales 4.19
Price/Cash Flow 32.98
Price/Book 3.59
Book Value/Share 10.32
Interest Coverage 3.43

LMNX Dividends

Date Value
06/16/21 $0.1000
03/24/21 $0.1000
12/22/20 $0.1000
09/23/20 $0.0900
06/17/20 $0.0900
03/18/20 $0.0900
12/18/19 $0.0900
09/25/19 $0.0900
06/19/19 $0.0600
03/20/19 $0.0600
12/19/18 $0.0600
09/20/18 $0.0600
06/21/18 $0.0600
03/22/18 $0.0600
12/21/17 $0.0600
09/21/17 $0.0600
06/21/17 $0.0600
03/22/17 $0.0600
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar